1. 14 24 31 62 Pathway for patients with suspected Skin Cancer
NB. Basal Cell Carcinoma is excluded from the 2 week cancer pathway
Maximum wait in days
2ww referral received in secondary care
Provide information and psychological support 14
First Specialist Assessment
Clinical History
Physical Examination
Holistic assessment and rehabilitation consideration
Yes
Is SCC or MM Suspected? No
Patient discharged with information on self assessment and prevention
First treatment?
Initial biopsy of lesion 10
Is SCC or MM confirmed? No
Pathology results discussed with patient
Patient discharged with information on self assessment and prevention
Yes
16-18 years old – refer to Paediatric Oncology (GNCC) for treatment and TYA MDT for discussion
19-24 years old – continue on tumour site specific pathway & refer to TYA MDT for discussion.
Is further treatment required? No
Patient discharged with information on self assessment/prevention and follow up arranged
See TYA pathway
Inform patient’s GP
Yes
Allocate Skin CNS/ Key Worker
Yes
Local MDT discussion
Inter provider transfer point 24
Refer for discussion at Specialist MDT as required
Liaise & involve healthcare professionals as required 7
Specialist MDT to discuss investigation, treatment & Rehabilitation plan plus consideration for clinical trials
Decision to treat date
Treatment plan agreed with patient 31
FNA
Imaging
Sentinel Node Biopsy
Further staging investigations as required 31
First treatment 62
Dermatology
Plastic Surgery
OMF Surgery
Radiotherapy
Chemotherapy
Specialist MDT discussion
Is further treatment required?
Yes
Earliest Clinically Appropriate Date for commencement of subsequent treatment
ECAD Date No
Appropriate after care
Skin Cancer Pathway [Final]